Can diabetic patients receive methylprednisolone infusion?

Administering methylprednisolone may refer to the intravenous use of methylprednisolone sodium succinate for injection. Diabetic patients can receive methylprednisolone, but must do so under medical supervision. The detailed analysis is as follows:

Methylprednisolone sodium succinate for injection is commonly used to treat rheumatic diseases, collagen diseases, and other conditions, providing anti-inflammatory and immunosuppressive effects. Diabetic patients who also have autoimmune or allergic diseases may use methylprednisolone sodium succinate for injection as an adjunctive therapy under a doctor's guidance to help control their condition. However, this medication may affect blood glucose control in diabetic patients, potentially leading to elevated blood sugar levels, worsening of the disease, and even serious complications. Therefore, it is recommended that diabetic patients consult their physician before using this medication to ensure it is appropriate for their condition.

In daily life, patients should also develop healthy lifestyle habits, engage in appropriate physical activity, and avoid high-sugar, high-fat foods such as cakes and fried chicken, to maintain stable blood glucose levels.